# OnCo record hira (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/hira/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "hira" ;
  schema:name "Health Insurance Review and Assessment Service (HIRA)"@en ;
  schema:alternateName "HIRA"@en, "건강보험심사평가원"@en, "심평원"@en ;
  schema:description "The Korean public body that decides whether national health insurance should pay for a new cancer drug, by judging how well it works and whether it is worth its price."@en ;
  schema:url <https://onco.cc/institutions/hira/>, <https://www.hira.or.kr> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.hira.or.kr/dummy.do?pgmid=HIRAJ010000009001>, <https://www.dailypharm.com/user/news/9684>, <https://m.dailypharm.com/user/news/334595>, <https://dailypharm.com/user/news/7495> ;
  schema:addressCountry "KR" ;
  schema:addressLocality "Wonju" ;
  schema:latitude "37.322"^^xsd:decimal ;
  schema:longitude "127.981"^^xsd:decimal ;
  onco:related <https://onco.cc/institutions/g-ba-iqwig/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:institutions <https://onco.cc/institutions/nhis-korea/>, <https://onco.cc/institutions/mfds/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-kim-managed-entry-agreements-korea-front-pharmacol-2023/>, <https://onco.cc/key-papers/paper-kim-anticancer-pricing-reimbursement-korea-erpor-2021/> .